Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.
Journal article
Goodwin GM. et al, (2024), Am J Psychiatry, 181, 79 - 81
Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial.
Journal article
Landrø NI. et al, (2023), Contemporary clinical trials, 133, 107326 - 107326
The psychedelic experience and treatment-resistant depression.
Journal article
Goodwin GM., (2023), World Psychiatry, 22, 420 - 422
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
Journal article
Dougherty RF. et al, (2023), Psychopharmacology (Berl)
Reducing intrusive memories after trauma via an imagery-competing task intervention in COVID-19 intensive care staff: A randomised controlled trial Running title: Imagery-competing task intervention after trauma
Journal article
IYADURAI L. et al, (2023), Translational Psychiatry
The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorder.
Journal article
Steel C. et al, (2023), Int J Bipolar Disord, 11
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
Journal article
Goodwin GM. et al, (2023), Neuropsychopharmacology
Must Psilocybin Always "Assist Psychotherapy"?
Journal article
Goodwin GM. et al, (2023), Am J Psychiatry
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression
Journal article
Jauhar S. et al, (2023), Molecular Psychiatry
Psilocybin for Treatment-Resistant Depression. Reply.
Journal article
Goodwin GM. et al, (2023), N Engl J Med, 388
Unblinding and demand characteristics in the treatment of depression.
Journal article
Goodwin GM. et al, (2023), J Affect Disord, 328, 1 - 5
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
Journal article
Goodwin GM. et al, (2023), J Affect Disord
Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice
Journal article
Thomas CW. et al, (2022), Translational Psychiatry, 12
Identifying psychiatric diagnosis from missing mood data through the use of log-signature features
Journal article
Wu Y. et al, (2022), PLOS ONE, 17, e0276821 - e0276821
Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder.
Journal article
Joas E. et al, (2022), Pharmacogenomics J
Excess resource use and costs of physical comorbidities in individuals with mental health disorders: A systematic literature review and meta-analysis.
Journal article
Simon J. et al, (2022), Eur Neuropsychopharmacol, 66, 14 - 27
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
Journal article
Goodwin GM. et al, (2022), N Engl J Med, 387, 1637 - 1648
Using a generative model of affect to characterize affective variability and its response to treatment in bipolar disorder
Journal article
Pulcu E. et al, (2022), Proceedings of the National Academy of Sciences, 119
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs.
Journal article
Similon MVM. et al, (2022), Eur Neuropsychopharmacol, 60, 91 - 99
The costs of bipolar disorder in the United Kingdom.
Journal article
Simon J. et al, (2021), Brain Behav